The American Journal of Psychiatry
Official Journal of the American Psychiatric Association
Edited by Ned H. Kalin, M.D.
- Item #AJP
Recognition for The American Journal of Psychiatry
- An Impact Factor of 13.655 ranks AJP among the highest not just in psychiatry but ahead of 99% of the rest of the publishing world.
- Two of Journal Watch Psychiatry's Top Stories of 2019
- Three of Brain & Behavior Research Foundation's top advancements and breakthroughs of 2019
- Four current Deputy Editors of the Journal named to the Clarivate Analytics 2018 Highly Cited Researchers list
Watch the AJP Video Series
Committed to keeping the field of psychiatry vibrant and relevant by publishing the latest advances in the diagnosis and treatment of mental illness, The American Journal of Psychiatry (AJP) is one of the most widely read psychiatric journals in the world and is the journal that the overwhelming majority of psychiatrists considers essential. Published monthly, it is an indispensable journal for all psychiatrists and other mental health professionals who need to stay on the cutting edge of virtually every aspect of psychiatry.
AJP in Advance—As part of the Journal’s commitment to bringing the latest research to the field faster, all research articles now appear online in advance of their appearance in a print issue. AJP in Advance is updated with new articles on the 1st and 15th of each month (or the next business day).
No other psychiatric journal reaches more psychiatrists with greater impact or immediacy than The American Journal of Psychiatry, the journal that the overwhelming majority of psychiatrists consider essential. The findings presented in AJP explore the full spectrum of issues related to mental health diagnoses and treatment, with editorials that place the most groundbreaking research into clinical context.
To visit the American Journal of Psychiatry online, please visit http://ajp.psychiatryonline.org
Highlights from the April issue of American Journal of Psychiatry:
The April issue of The American Journal of Psychiatry discusses comprehensive community care for first-episode psychosis, identification of distinct psychosis biotypes, evidence-based treatment of young people whose psychotic symptoms have not yet reached full diagnostic criteria for a psychotic disorder, and how increased and decreased appetite in depression compare in terms of neurocircuitry. Two trials of treatments for major depression are also featured: one tested lurasidone treatment for major depressive disorder with mixed features; the other compared bitemporal ECT with high-dose unilateral ECT given twice a week.
Ned H. Kalin, M.D.
Elisabeth Binder, M.D., Ph.D.
Kathleen T. Brady, M.D., Ph.D.
David A. Lewis, M.D.
Daniel S. Pine, M.D.
Carolyn Rodriguez, M.D., Ph.D.
Madhukar Trivedi, M.D.
Huda Akil, Ph.D.
Melissa Arbuckle, M.D., Ph.D.
Alan Brown, M.D., M.P.H.
Tyrone Cannon, Ph.D.
Karl Deisseroth, M.D., Ph.D.
Benjamin G. Druss, M.D., M.P.H.
Felton Earls, M.D.
Graham J. Emslie, M.D.
Javier I. Escobar, M.D., M.Sc.
Julie L. Fudge, M.D.
Qiyong Gong, M.D., Ph.D.
Helena Hansen, M.D., Ph.D.
Yasmin Hurd, Ph.D.
Clinton D. Kilts, Ph.D.
Carlos Lopez Jaramillo, M.D., M.Sc., Ph.D.
Joan L. Luby, M.D.
Constantine G. Lyketsos, M.D., M.H.S.
Helen S. Mayberg, M.D., F.R.C.P.C.
Terrie E. Moffitt, Ph.D.
Rajesh Narendran, M.D.
Charles B. Nemeroff, M.D., Ph.D.
Roy Perlis, M.D.
Bryan L. Roth, M.D., Ph.D.
Alan F. Schatzberg, M.D.
Anita Thapar, M.B.B.Ch., F.R.C.Psych., Ph.D., F.Med.Sci.
Mauricio Tohen, M.D., Dr.PH., M.B.A.
Giulio Tononi, M.D., Ph.D.
Eduard Vieta, M.D., Ph.D.
John T. Walkup, M.D.
Nancy C. Andreasen, M.D., Ph.D.
Robert Freedman, M.D.
Amariah Brigham, M.D., 1844–1849
T. Romeyn Beck, M.D., 1849–1854
John P. Gray, M.D., 1854–1886
G. Alder Blumer, M.D., 1886–1894
Richard Dewey, M.D., 1894–1897
Henry M. Hurd, M.D., 1897–1904
Edward N. Brush, M.D., 1904–1931
Clarence B. Farrar, M.D., 1931–1965
Francis J. Braceland, M.D., 1965–1978
John C. Nemiah, M.D., 1978–1993
About the Authors
Ned H. Kalin, M.D., University of Wisconsin–Madison School of Medicine and Public Health
Dr. Kalin is among the most accomplished biological psychiatrists, working to understand the brain mechanisms underlying mental disorders. He is currently Hedberg Professor and Chair of the Department of Psychiatry at the University of Wisconsin School of Medicine and Public Health. Kalin also serves as the Director of the Health Emotions Research Institute and Director of the Lane Neuroimaging Laboratory, both at the University of Wisconsin School of Medicine and Public Health. He is a member of the National Academy of Medicine, a Distinguished Fellow of the APA, and serves on the APA Council on Research. His special area of research interest is anxiety disorders, and he has led a robust research effort at the University of Wisconsin that encompasses molecular, preclinical, and human neuroimaging approaches focused on understanding molecular and neural circuit alterations that underlie the childhood risk for anxiety and depression.